Amlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg Of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets Of 30 Mg; Ambroxol, Solution For Injection/Infusion 7.5 Mg/Ml, 2 Ml; Ascorbic Acid Solution For Injection, 100 Mg/Ml Of 2 Ml; Potassium . More

КОМУНАЛЬНЕ НЕКОМЕРЦІЙНЕ ПІДПРИЄМСТВО ЧЕРКАСЬКИЙ ОБЛАСНИЙ ПРОТИТУБЕРКУЛЬОЗНИЙ ДИСПАНСЕР ЧЕРКАСЬКОЇ ОБЛАСНОЇ РАДИ Ukraine has Released a tender for Amlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg Of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets Of 30 Mg; Ambroxol, Solution For Injection/Infusion 7.5 Mg/Ml, 2 Ml; Ascorbic Acid Solution For Injection, 100 Mg/Ml Of 2 Ml; Potassium . More in Pharmaceuticals. The tender was released on May 22, 2025.

Country - Ukraine

Summary - Amlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg Of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets Of 30 Mg; Ambroxol, Solution For Injection/Infusion 7.5 Mg/Ml, 2 Ml; Ascorbic Acid Solution For Injection, 100 Mg/Ml Of 2 Ml; Potassium . More

Deadline - Jun 06, 2025

GT reference number - 109443911

Product classification - Medicinal products for the alimentary tract and metabolism